Login / Signup

Estimating hepatitis C prevalence in the United States, 2017-2020.

Eric William HallHeather BradleyLaurie K BarkerKaron C LewisJalissa ShealeyEduardo ValverdePatrick Sean SullivanNeil GuptaMegan G Hofmeister
Published in: Hepatology (Baltimore, Md.) (2024)
Despite years of an effective cure, the estimated prevalence of hepatitis C in 2017-2020 remains unchanged from 2013 to 2016 when using a comparable methodology. When accounting for increased injection drug use, the estimated prevalence of hepatitis C is substantially higher than previously reported. National action is urgently needed to expand testing, increase access to treatment, and improve surveillance, especially among medically underserved populations, to support hepatitis C elimination goals.
Keyphrases
  • risk factors
  • public health
  • ultrasound guided
  • combination therapy
  • genetic diversity